Dasatinib in Combination With Revlimid (and Dexamethasone)
Clinical trial NCT00560391 · COMPLETED
Trial details
- NCT number
- NCT00560391
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2011-10-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.